Published in Biol Trace Elem Res on August 01, 1987
Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol (2001) 3.84
In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol (1985) 2.46
In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med (1988) 2.43
Three-dimensional imaging of dislocations in a nanoparticle at atomic resolution. Nature (2013) 2.37
Unexpected mobilisation of lead during cisplatin chemotherapy. Lancet (1986) 1.95
Cadmium fume inhalation and emphysema. Lancet (1988) 1.84
Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem (2001) 1.65
In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health (1993) 1.47
Lead in bone: sampling and quantitation using K X-rays excited by 109Cd. Environ Health Perspect (1991) 1.46
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. Phys Med Biol (1989) 1.46
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements. Phys Med Biol (1986) 1.35
Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism (2001) 1.32
Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics (1992) 1.26
Improvements in the precision of in vivo bone lead measurements. Phys Med Biol (1989) 1.26
Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol (1998) 1.25
Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine. Gastroenterology (1997) 1.22
The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res (2000) 1.11
Kidney effects in long term exposed lead smelter workers. Br J Ind Med (1992) 1.11
Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun (2000) 1.10
New method of serological testing for Mycobacterium avium subsp. paratuberculosis (Johne's disease) by flow cytometry. Foodborne Pathog Dis (2005) 1.08
Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure. Br J Ind Med (1992) 1.07
Molecular profiling reveals prognostically significant subtypes of canine lymphoma. Vet Pathol (2012) 1.03
Renal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations. Lancet (1983) 0.97
In vivo elemental analysis in occupational medicine. Scand J Work Environ Health (1986) 0.97
The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci (2001) 0.96
Chelated lead and bone lead. Scand J Work Environ Health (1992) 0.93
Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. Br J Ind Med (1988) 0.92
Borrelia burgdorferi not detected in widespread Ixodes scapularis (Acari: Ixodidae) collected from white-tailed deer in Tennessee. J Med Entomol (2012) 0.91
Longitudinal studies of exposure to cadmium. Br J Ind Med (1992) 0.86
Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects. J Clin Endocrinol Metab (2004) 0.85
An improved in vivo neutron activation system for measuring kidney cadmium. Phys Med Biol (1990) 0.84
Genetic segregation analysis of red blood cell (RBC) histamine N-methyltransferase (HNMT) activity. Genet Epidemiol (1993) 0.84
Effect of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels. Hum Exp Toxicol (1990) 0.82
Delivery of comprehensive children's dental services using portable dental clinics in NYC public schools. A six-year analysis. N Y State Dent J (1997) 0.80
Measurements of trace elements in vivo. Basic Life Sci (1990) 0.78
Monte Carlo modelling of in vivo x-ray fluorescence of lead in the kidney. Phys Med Biol (1991) 0.78
Direct measurement of dopamine O-sulfate in plasma and cerebrospinal fluid. J Chromatogr (1987) 0.78
Design studies related to an in vivo neutron activation analysis facility for measuring total body nitrogen. Phys Med Biol (1992) 0.78
In vivo neutron activation analysis of organ cadmium burdens. Referent levels in liver and kidney and the impact of smoking. Biol Trace Elem Res (1991) 0.77
Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors. Agents Actions (1993) 0.77
Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors. Vet Comp Oncol (2013) 0.77
Miao et al. reply. Nature (2013) 0.75
Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci (1986) 0.75
The use of multiple parameters to characterize cadmium-induced renal dysfunction resulting from occupational exposure. Environ Res (1994) 0.75
Fast neutron spectrum measurements in anthropomorphic phantoms using an NE213 scintillation spectrometer. Phys Med Biol (1987) 0.75
In situ neutron spectrometry to 60 MeV in a water phantom exposed to a cancer therapy beam. Phys Med Biol (1991) 0.75
Changes in the rate of cortical epileptiform activity by increased intragastric pressure in cats. Exp Neurol (1981) 0.75
Multiple therapies for vaginal bleeding secondary to large uterine myomas. Int J Gynaecol Obstet (1991) 0.75
On the in vivo measurement of mercury using neutron capture and x-ray fluorescence. Int J Appl Radiat Isot (1982) 0.75
A pilot study using 99mTc to measure lead and platinum in the human kidney. Nucl Med Biol (1993) 0.75
In-phantom neutron fluence measurements in the orthogonal Birmingham boron neutron capture therapy beam. Med Phys (1998) 0.75
Feasibility studies in the in vivo measurement of iron in synovial membrane. Basic Life Sci (1990) 0.75